CG inks MoUs with 5 major bodies to align healthcare services with global standards
Raipur: Chhattisgarh govt on Thursday signed an Memorandum of Understanding (MoU) with five prominent national and international institutions to bring state healthcare system, in line with the global benchmarks and strengthen service delivery across all regions.
The agreement was formalized by Health Minister Shri Shyam Bihari Jaiswal at Mahanadi Bhawan in Nava Raipur during a ceremony.
Jaiswal said, "With this collective effort, we aim to position Chhattisgarh as a leading state in
national health indices
and deliver services that are efficient, transparent, and compassionate.
"Among the five institutions
United Nations Development Programme
which will provide strategic and technical assistance to state immunization programmes.
AIIMS Raipur will support improvements in
maternal and child healthcare
, Center for Catalyzing Change will bolster adolescent health and awareness under National Adolescent Health Programme, Bihar Voluntary Health Association will implement targeted health interventions among marginalized lot and NIMHANS will oversee the expansion and reinforcement of mental health services in the state.
Action plans with WHO and UNICEF were discussed focusing on disease surveillance, nutrition, child and maternal health, and broader public health resilience.
Secretary of public health Amit Kataria, commissioner and cirector Priyanka Shukla were present.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
3 days ago
- Business Standard
AstraZeneca sets up ₹166 cr Global Hub to boost AI driven healthcare
Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 crore to focus on development of AI-powered healthcare solutions, a top official said on Thursday. This marks the second major investment by AstraZeneca in July 2024 after it announced expansion of its Global Innovation and Technology Centre in Chennai with an outlay of Rs 250 crore. The new facility in Bengaluru is designed to accommodate nearly 1,300 employees including 400 new jobs. It will support the company's capabilities in AI-powered innovation across Research and Development, global business services, Information Technology and digital health operations, among others. The Global Hub in Bengaluru is dedicated to Research and Development, Global Business Services, Information Technology while the Global Innovation and Technology Centre in Chennai serves as a strategic hub for IT, Global Business Services. Following the expansion of the facility, the combined workforce of AstraZeneca India Pvt Ltd would reach close to 4,000 employees, strengthening company's capability to deliver life-changing medicines to patients worldwide. Commenting on the development, company Vice President Global Business Services, Jackie Crockford said, "Our Global Hub in Bengaluru is a strategic investment that will play a vital role in advancing AstraZeneca's bold ambition to deliver 20 new medicines by 2030 by strengthening automated, scalable, data-driven and patient centric solutions." "This step reflects our commitment to tapping into the world-class talent and ecosystem available in Karnataka to power the next generation of scientific innovation." he said in a company statement here. The new facility would serve as a dynamic hub in advanced clinical research supporting AstraZeneca's global therapeutic areas, development of AI-powered healthcare solutions, centralised data analytics to enhance clinical trial efficiency among others. AstraZeneca Global Patient Safety BioPharma, Vice-President Magnus Nord said, "This hub enhances our Research and Development capabilities by connecting us with India's exceptional scientific and technological expertise." The expansion would accelerate the development of innovative medicines and deliver across Research and Development, ultimately benefitting patients around the world", Nord said. The Global Hub reflects AstraZeneca's dedication to environmental sustainability and the facility is designed to achieve LEED Platinum certification. It is currently powered by 75 per cent green energy. It has waste-water recycling, Internet-of-Things (IoT) enabled systems for optimised energy management among others.
India Today
4 days ago
- India Today
Why routine health checks are crucial during the monsoon season
The monsoon season, although providing a much-needed reprieve from the blazing summer heat, also brings a slew of health issues. Increased humidity, stagnant water and variable temperatures promote the spread of different diseases. Routine health check-ups are essential at this time for detecting and avoiding illnesses and ensuring overall spoke with Dr Rashmi Khadapkar, Senior Research Scientist and Senior DGM – R&D Operations at Agilus and Dr Kunal Sharma, Head of Centre of Excellence (COE) and Histopathology at Agilus to get more insights on the Surge in waterborne and vector-borne diseases Waterborne illnesses such as typhoid, hepatitis A, and cholera are prevalent during the monsoon season due to contaminated water sources. Stagnant water also serves as a breeding ground for mosquitoes, which increases the risk of vector-borne diseases like dengue, malaria and chikungunya. For instance, Pune reported a significant spike in hepatitis and typhoid infections in May 2025 compared to the previous health screenings aid in the early detection of certain diseases, allowing for timely intervention and reducing the risk of consequences.2. Exacerbation of respiratory and gastrointestinal issuesThe damp and humid conditions during monsoon can aggravate respiratory ailments such as asthma, bronchitis, and allergies. Mold growth and increased pollen count further contribute to respiratory distress. Furthermore, fluctuations in temperature can cause gastrointestinal issues such as diarrhoea and food poisoning. For example, Nagpur saw an increase in diarrhoea cases due to shifting weather conditions and poor Monitoring chronic conditionsPatients with chronic illnesses such as diabetes, hypertension and arthritis may experience worsening symptoms during the monsoon season. High humidity can affect blood sugar levels and increase joint pain. Routine check-ups assist in closely monitoring these conditions, allowing for timely adjustments in treatment plans.4. Strengthening immunity and nutritional assessmentSudden weather changes can weaken the immune system, making individuals more susceptible to infections. Regular health checkups provide insights into one's overall health and immune function. Doctors may recommend vitamin supplements and dietary changes to bolster immunity.5. Mental health considerationsThe gloomy and dark monsoon days may have a significant impact on mental health, potentially triggering conditions such as Seasonal Affective Disorder (SAD) and mood swings. Regular check-ups, including mental health evaluations, can help in diagnosing and managing these disorders, thereby ensuring overall HEALTH CHECK-UPS DURING MONSOONA comprehensive monsoon health check-up typically includes:Complete Blood Count (CBC): To detect infections and assess overall and Kidney Function Tests: To monitor organ health, especially if affected by waterborne and Malaria Tests: Particularly if experiencing fever or flu-like X-ray: For individuals who are prone to respiratory Assessment: To diagnose deficiencies and suggest dietary MEASURES TO COMPLEMENT HEALTH CHECK-UPS Maintain Hygiene: Infections can be avoided by regularly washing your hands and keeping your living space clean and Hydrated: Drink plenty of clean, boiled, or purified water to prevent dehydration and associated a Balanced Diet: Include foods rich in Vitamin C and antioxidants to boost the immune Stagnant Water: To avoid mosquito breeding, remove any standing water around the Protection: Mosquito repellents and nets are essential to prevent vector-borne Dry: Change out of wet clothes promptly to prevent skin Safety: Ensure that all food is well-cooked, and avoid eating from street vendors during the monsoon.- Ends
Time of India
6 days ago
- Time of India
THIS common condition may speed up Alzheimer's disease: Experts recommend a simple blood test to determine it
A recent study presented at the European Academy of Neurology Congress 2025 reveals that a blood test could predict rapid cognitive decline in early Alzheimer's patients. Researchers at the University of Brescia found insulin resistance, measured by the TyG index, significantly accelerates the disease's progression. Alzheimer's disease, which is the most common type of dementia, is on the rise. About 57 million people had dementia worldwide in 2021, and the numbers are escalating. This progressive neurodegenerative disorder affects the quality of life, even impacting daily activities, and hence, early diagnosis is crucial. Researchers have now found that a simple blood test may soon help doctors predict which patients with early Alzheimer's disease are most at risk of rapid cognitive decline. They also found that a common condition related to metabolic disorders could dramatically accelerate the disease. The research was led by neurologists at the University of Brescia in Italy and was presented at the European Academy of Neurology (EAN) Congress 2025. Common condition linked to accelerated Alzheimer's disease The common condition in question is insulin resistance . The researchers looked at the records of 315 non-diabetic patients with cognitive deficits, including 200 with biologically confirmed Alzheimer's disease. All participants underwent a TyG index assessment and were followed clinically over three years. The researchers found that the patients in the highest third of the TyG index within the Mild Cognitive Impairment-AD subgroup declined significantly faster than those with lower readings, losing more than 2.5 points per year on the widely used Mini-Mental State Examination. The ratio for rapid progression was 4.08 (95% CI 1.06–15.73), which is a fourfold increase in risk. 'Once mild cognitive impairment is diagnosed, families always ask how fast it will progress. Our data show that a simple metabolic marker available in every hospital laboratory can help identify more vulnerable subjects who may be suitable candidates for targeted therapy or specific intervention strategies,' lead investigator Dr Bianca Gumina said in a statement. Impact of insulin resistance on Alzheimer's disease Though previous research has shown the association between insulin resistance and Alzheimer's disease , its role in how quickly the condition progresses has not been much explored. This recent study looked into insulin resistance's impact during the prodromal mild cognitive impairment (MCI) stage, when patients follow highly variable trajectories. What is insulin resistance Insulin resistance is a condition where the body's cells do not respond properly to insulin. Insulin is a hormone produced by the pancreas that helps glucose (sugar) enter cells for energy. To compensate, the pancreas produces more insulin, but over time, this can lead to elevated blood sugar levels (hyperglycemia), increasing the risk of type 2 diabetes and other serious health conditions. The study The researchers used the TyG index, a simple and affordable way to measure insulin resistance, to see if metabolic problems could help predict how quickly cognitive decline happens after diagnosis. 'We were surprised to see the effect only in the Alzheimer's spectrum and not in other neurodegenerative diseases. It suggests a disease-specific vulnerability to metabolic stress during the prodromal window, when interventions may still change the trajectory', Dr Gumina added. Salman Khan Drops Health Bombshell on National TV The researchers at the University of Brescia, led by Professor Padovani and Professor Pilotto, found that high TyG was also associated with blood–brain barrier disruption and cardiovascular risk factors. However, it showed no interaction with the APOE ε4 genotype, and hinted that metabolic and genetic risks may act through distinct pathways. 'If targeting metabolism can delay progression, we will have a readily modifiable target that works alongside emerging disease-modifying drugs', Dr Gumina concluded. One step to a healthier you—join Times Health+ Yoga and feel the change
